Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 3
1 (50.0%)Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting
Phase 3
Recruiting
- Conditions
- Burn (Disorder)Burn Degree SecondBurns Degree ThirdThermal BurnWound Heal
- Interventions
- Drug: Skin XenotransplantProcedure: Autograft(ing)
- First Posted Date
- 2024-01-25
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- XenoTherapeutics, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT06223269
- Locations
- 🇺🇸
MaineHealth Maine Medical Center, Portland, Maine, United States
🇺🇸Arizona Burn Center Valleywise Health, Phoenix, Arizona, United States
🇺🇸JMS Burn Center at Doctors Hospital, Augusta, Georgia, United States
Evaluation of Safety and Efficacy of realSKIN® (Skin Xenotransplant) for Complete Closure of Severe Burn Wounds
Phase 1
Completed
- Conditions
- Deep Full-thickness Burn Injury (Disorder)
- First Posted Date
- 2018-10-04
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- XenoTherapeutics, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT03695939
- Locations
- 🇺🇸
JMS Burn Center at Doctors Hospital, Augusta, Georgia, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
News
No news found